66 Matching Annotations
  1. Last 7 days
    1. Ratherthan framing AMP therapy as “personalized,” a more clinically grounded strategy involvespathogen-directed or susceptibility-guided AMP design informed by resistance phenotypesand epidemiological data

      not specific to the patient, specific to pathogen or qualities of the AMP

    2. unctional annotations of unknown sequences, genetic associations,disease links, and evolutionary relationships, their capacity to directly predict antimicrobialefficacy remains under active development

      AMP field still has many knowledge gaps

    3. Most AI models achieve high accuracy on predictinghemolytic and non-hemolytic AMPs; however, they also have a limitation on predictinghigh vs low hemolytic AMPs

      identifying patterns associated w/ hemolysis, but lacking precision

    4. However, a concern in the incorporation of liposomes in cationic AMPs has emerged, asleakage of these antimicrobials can occur due to hydrophobic and electrostatic interac-tions [210, 211 ]. The high production cost of liposomes

      liposomes work very effectively and solve several delivery challenges but are not perfect

    5. s molecular weight increases, the half-lives, retention in thebody and resistance to protease degradation increase, requiring a more complex metabolicprocess in the human body to excrete

      makes sense but did not realize this; larger moleculaes more likely to stick around

    6. fungal membranes contain ergosterol (the main fungalsterol) and glycosphingolipids, more specifically glucosylceramide (GlcCer), which areboth surrounded by a solid cell wall composed of chitin and β-glucans

      did not know how fungal walls were constructed

    7. C. auris producesextracellular polymeric substances that promote surface adhesion, biofilm formation andresistance to antifungal agents. These properties facilitate persistence on medical devices

      not that different from biofilm-producers

    8. binding to membrane componentsto disrupt membrane stability or synthesis and penetration of the cell to alter vital cell pro-cesses that ultimately lead to cell death

      interesting that they are specialized for this kind of function and not broader like antibiotics

    9. facilitating the design of peptides that selectively promote aggregation of bacterialproteins while minimizing off-target self-assembly or host toxicity.

      found evidence of beneficial effect of aggregation; ML can be used to optimize designs that serve greatest benefit and pose smallest harm to host

    10. AI-guided aggregationand solubility models play a central role in de-risking AMP development

      have identified biochem factors that often lead to aggregation; ML methods identify the patterns and screen those out, and can design peptides w/o those factors

  2. Sep 2026
    1. antimicrobialactivity emerges not only from amino acid composition but also from structural elementssuch as secondary structure, amphipathicity, solvent accessibility and conformational stabil-ity

      a variety of interacting factors impact antimicrobial capabilities

    2. n AMP discovery pipelines, RF models frequently outperform single-tree methods byreducing variance and improving generalization across diverse peptide families

      did not know it was this effective compared to other methods

    3. When immobilized onbiomaterials, AMPs can prevent bacterial colonization, disrupt early biofilm formationand extend the functional lifespan of medical device

      did not know AMPs had a preventative application; thought they could only be used to treat